CONCENTRATIONS OF PROCAINE AND AQUEOUS PENICILLIN IN THE CEREBROSPINAL-FLUID OF INFANTS TREATED FOR CONGENITAL-SYPHILIS

被引:11
作者
AZIMI, PH
JANNER, D
BERNE, P
FULROTH, R
LVOFF, V
FRANKLIN, L
BERMAN, SM
机构
[1] HIGHLAND GEN HOSP, DIV NEWBORN SERV, OAKLAND, CA USA
[2] CTR DIS CONTROL & PREVENT, ATLANTA, GA 30341 USA
关键词
D O I
10.1016/S0022-3476(05)83151-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Penicillin concentrations in cerebrospinal fluid (CSF) were measured at various hours and days of treatment in 163 infants undergoing therapy for congenital syphilis. The CSF levels were compared for three treatment regimens. Aqueous penicillin G (A-PEN), 100,000 U/kg per day, was used in 23 infants, and a dosage of 200,000 U/kg per day was used in 40 patients; procaine penicillin G (P-PEN), 50,000 U/kg per day, was used in 100 children. Mean CSF penicillin levels were 0.416, 0.493, and 0.077 mu g/ml, respectively, in the three treatment groups. The mean CSF penicillin concentration among the 63 infants treated with either of the A-PEN regimens (0.465 mu g/ml) was significantly greater than the mean concentration (0.077 mu g/ml) among those treated with P-PEN (p<0.001). Among those who received A-PEN, the difference in dosage was not associated with a significant difference in mean CSF penicillin concentration (p=0.68). All the specimens obtained from patients who received A-PEN, but only 82% of those from patients who received P-PEN, had treponemicidal concentrations (greater than or equal to 0.018 mu g/ml). However, 33.3% (9/27) of specimens from infants who received P-PEN, tested between 18 and 24 hours after a dose, had CSF penicillin concentrations <0.018 mu g/ml. These data suggest that administration of A-PEN may be the preferred therapy if CSF levels >0.018 mu g/ml are desired, especially for infants with severe disease or congenital neurosyphilis.
引用
收藏
页码:649 / 653
页数:5
相关论文
共 28 条
[1]  
BECKSAGUE C, 1987, PEDIATR INFECT DIS J, V6, P1061, DOI 10.1097/00006454-198706110-00014
[2]   SIMPLIFIED ACCURATE METHOD FOR ANTIBIOTIC ASSAY OF CLINICAL SPECIMENS [J].
BENNETT, JV ;
BRODIE, JL ;
BENNER, EJ ;
KIRBY, WMM .
APPLIED MICROBIOLOGY, 1966, 14 (02) :170-&
[3]   PHARMACOKINETICS OF AQUEOUS PENICILLINS IN CEREBROSPINAL-FLUID OF NEONATES [J].
BERNARD, B ;
TINSLEY, L ;
MAPP, J .
PEDIATRIC RESEARCH, 1978, 12 (04) :402-402
[4]   PENICILLIN LEVELS IN BLOOD AND CSF ACHIEVED BY TREATMENT OF SYPHILIS [J].
DUNLOP, EMC ;
ALEGAILY, SS ;
HOUANG, ET .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (23) :2538-2540
[5]   THE EFFECTIVE CONCENTRATIONS OF PENICILLIN INVITRO AND INVIVO FOR STREPTOCOCCI, PNEUMOCOCCI, AND TREPONEMA PALLIDUM [J].
EAGLE, H ;
FLEISCHMAN, R ;
MUSSELMAN, AD .
JOURNAL OF BACTERIOLOGY, 1950, 59 (05) :625-643
[6]  
Grove D.C., 1955, ASSAY METHODS ANTIBI
[7]  
HEWITT W, 1977, MICROBIOLOGICAL ASSA, P284
[8]  
IDSE O, 1972, B WORLD HLTH ORGAN S, V47, P51
[9]  
IDSE O, 1972, B WORLD HLTH ORG S, V47, P6
[10]   CLINICAL PHARMACOLOGY OF BENZATHINE PENICILLIN-G IN NEONATES WITH REGARD TO ITS RECOMMENDED USE IN CONGENITAL SYPHILIS [J].
KAPLAN, JM ;
MCCRACKE.GH .
JOURNAL OF PEDIATRICS, 1973, 82 (06) :1069-1072